396 results on '"Naito, Tateaki"'
Search Results
2. Nursing students’ self-assessed level of nursing skills at the time of graduation in a Japanese University: A retrospective observational study
3. Exploring the educational needs for severe immune-related adverse events of PD-1/PD-L1 inhibitors in advanced lung cancer: A single-center observational study
4. Report of two patients in whom comparisons of the somatic mutation profile were useful for the diagnosis of metastatic tumors
5. Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.
6. Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer.
7. Barriers in Nursing Practice in Cancer Cachexia: A Scoping Review
8. Days Spent at Home near the End of Life in Japanese Elderly Patients with Lung Cancer: Post hoc Analysis of a Prospective Study
9. Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer.
10. Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer
11. Uniting for Greater Impact: The Crucial Role of Oncology Nurses in Cancer Care
12. The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey
13. Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study
14. Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
15. Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
16. The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey.
17. Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer
18. Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia
19. Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer: A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program
20. Impact of Cancer Cachexia on Hospitalization-associated Physical Inactivity in Elderly Patients with Advanced Non-small-cell Lung Cancer
21. Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials
22. Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy
23. Acquired immunodeficiency associated with thymoma: a case report
24. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol
25. Impact of Early Chemotherapy Resumption on the Outcome after Staphylococcus aureus Bacteremia in Patients with Solid Tumors: A Retrospective Study in a Single Tertiary Cancer Center in Japan.
26. Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status
27. Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study
28. Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
29. Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?
30. Characteristics of cellular composition in malignant pericardial effusion and its association with the clinical course of carcinomatous pericarditis
31. The effects of advanced age and serum α1‐acid glycoprotein on docetaxel unbound exposure and dose‐limiting toxicity in cancer patients
32. Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy
33. Clinical impact of tumour burden on the efficacy of PD ‐1/ PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer
34. O15-1 Responder analysis of anamorelin in patients with cancer cachexia
35. MO44-5 The clinical outcome of patients with oligometastatic non-small cell lung cancer treated with first-line immunotherapy
36. EL08 Supportive care in cancer
37. Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer
38. Cardiac Dysfunction Caused by Osimertinib
39. A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy
40. Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study.
41. Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer
42. Uniting for greater impact: The crucial role of oncology nurses in cancer care
43. The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
44. O2-2-5 - Survival data of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected NSCLC
45. SY21-3 - Progress in multimodal intervention for cancer cachexia
46. Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma
47. Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer.
48. Pulmonary Pleomorphic Carcinoma: A Clinicopathological Study Including EGFR Mutation Analysis
49. Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors
50. Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.